Who owns Franklin Templeton Etf Tr genomic adv etf?
- Ticker: HELX
- CUSIP Number: 35473p520
Tip: Access positions for across all investors
Analyze quarterly positions in Franklin Templeton Etf Tr genomic adv etf with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Franklin Templeton Etf Tr genomic adv etf stock
Who bought or sold Franklin Templeton Etf Tr genomic adv etf this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| LPL Financial | 9.1k | $282k | -58% | Sep 2025 |
|
| Advisor Group Holdings | 3.1k | $96k | 0% | Sep 2025 |
|
| Harbour Investments | 1.6k | $50k | -3% | Sep 2025 |
|
| Halbert Hargrove Global Advisors | 402.00 | $12k | 0% | Sep 2025 |
|
| Morgan Stanley | 1.00 | $43.000000 | 100% | Jun 2025 |
|
Who sold out of Franklin Templeton Etf Tr genomic adv etf?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Citadel Advisors | Jun 2025 | 63k | $1.8M |
| Raymond James Financial | Jun 2025 | 1.5k | $42k |
| UBS Group | Jun 2025 | 863.00 | $24k |